Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 20 | 0 | 189 | 464 | 663 |
| Gross Profit | 20 | N/A | 189 | 464 | 663 |
| Operating Expenses | 18,733 | 15,443 | 6,819 | 6,808 | 7,762 |
| Operating Income | -18,713 | -15,443 | -6,630 | -6,344 | -7,099 |
| Other Income | 3,752 | 1,014 | 47 | -76 | -151 |
| Pre-tax Income | -14,961 | -14,429 | -6,583 | -6,420 | -7,250 |
| Net Income Continuous | -14,961 | -14,429 | -6,583 | -6,420 | -7,250 |
| Net Income | $-14,961 | $-14,429 | $-6,583 | $-6,420 | $-7,250 |
| EPS Basic Total Ops | -0.16 | -0.21 | -0.21 | -0.21 | -0.24 |
| EPS Basic Continuous Ops | -0.16 | -0.21 | -0.21 | -0.21 | -0.24 |
| EPS Diluted Total Ops | -0.16 | -0.21 | -0.21 | -0.21 | -0.24 |
| EPS Diluted Continuous Ops | -0.16 | -0.21 | -0.21 | -0.21 | -0.24 |
| EBITDA(a) | $-20,502 | $-15,144 | $-6,623 | $-6,381 | $-7,049 |